BREAKING NEWS

BREAKING NEWS ""**If we want PSU bank to compete with Pvt bank ---Give them a break Saturday first*** DA FOR BANKER FROM FEBRUARY 2023 SEE DETAILS CHART FOR OFFICER AND WORKMAN***Outcome of Today’s meeting with IBA - 31.01.2023***All India Bank Strike 27.06.2022******PLEASE VISIT INDIAN TOURISM CULTURE & HERITAGE *****NITI Aayog finalised names of Two public sector banks and one general Insurance Co. for privatisation****No economic reason to privatise PSU banks---post date 24.05.2021******Mobile users may soon be able to switch from postpaid to prepaid and vice versa using OTP*****India May Privatise or Shut 46 PSUs in First 100 Days, Says NITI Aayog's Rajiv Kumar----We should start with the banks*****Expected DA for Bank Employee from August 2019 is 24 slab to 29 slab*****RTGS time window from 4:30 pm to 6:00 pm. with effect from June 01.06.2019******WITHOUT CUSTOMER'S CONSENT BANK CAN NOT USE AADHAAR FOR KYC ----RBI***** Salient features of Sukanya Samriddhi Account---Who can open and how?******OBC posts 39% rise in Q4 profit, OBC readt tWITHOUT CUSTOMER'S CONSENT BANK CAN NOT USE AADHAAR FOR KYC ----RBI o take another Bank--MD MUkesh Jain*******DA FOR BANKER FROM NOV 2018 IS INCREASE 66 SLAB I.E 6.60%****40,000 STANDARD DEDUCTION IN YOUR TAX - IS A GREAT DRAM/BLUFF BY JAITLY SEE DETAILS+++++++Cabinet approves plans to merge PSU banks-The final scheme will be notified by the central government in consultation with the Reserve Bank. post date 23.08.2017****IBA to restrict the negotiations on Charter of Demands of Officers' Associations up to Scale-III only post dated 07.07.2017*****

VISITOR FROM WORLD

Free counters!

YOU ARE VISITOR

Blog Archive

LIVE

BREAKING NEWS ""**If we want PSU bank to compete with Pvt bank ---Give them a break Saturday first****Outcome of Today’s meeting with IBA - 31.01.2023*********

Saturday, May 8, 2021

Must know about ***REMDesiVir***

🔆
 *Must know ..* 

*Remdesivir* Is Developed By Gilead Science, A Pharmaceutical Based In Foster City, California. 

The Drug Was Developed By *RAMESH E.M. DESIGAN*  Team Led By Czech Scientist Tomas Cihlar, Primarily For Treatment Of Ebola Virus.

 *Not Many Know Of The Story* *Behind The* *Development & Naming Of This* *Drug* .

It Is Actually Named After *Ramesh E.M. Desigan*, The Lead Scientist In The Team Of Tomas Cihlar.

 *Ramesh* Hails From Rasipuram, Near Salem In Tamil Nadu. Coming From A Poor Family, Ramesh Received A Scholarship To Study At Madras Christian College, Followed By A PhD In Pharmacology From "JNU" New Delhi.

In 2002 *Ramesh* Moved To California, To Work For Gilead Sciences & Was Instrumental In Identifying The Viral Pathway, That Could Be Blocked By Anti-viral Drugs.

Initially Called Ebpantuvir, The Name Was Changed In Honor Of The Inventor Of The Drug To *"REMDesiVir"*.

Additionally In Honor Of This Discovery, Gilead Donated $2 Million To The Rasi International School Where He Did His Primary Education.But very few Indians know about this interesting story.. ..

No comments:

CBI HAS FILEDA CHARGE SHEET AGAINST CMD OF BOI AND OBC

The Central Bureau of Investigation (CBI) has filed a charge sheet against Alok Kumar Misra, the former chairman and managing director (CMD)...

script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js">